A Phase II study of Viagenpumatucel-l (HS-110) in combination with low-dose Cyclophosphamide versus physician's choice in patients with advanced non-small cell lung cancer

Cohen, Roger B; Nemunaitis, John; Gabrail, Nashat; Bazhenova, Lyudmila; Schreiber, Taylor H; Price, Melissa

doi:10.1186/2051-1426-2-S3-P82

Article metrics
Last updated: Wed, 24 Apr 2024 18:48:22 Z

A Phase II study of Viagenpumatucel-l (HS-110) in combination with low-dose Cyclophosphamide versus physician's choice in patients with advanced non-small cell lung cancer

Access & Citations

887

Article Accesses
0

Web of Science
1

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.